查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1886053

全球疏水交互作用层析法市场

Hydrophobic Interaction Chromatography
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球疏水交互作用层析法市场预计到2030年将达到7.163亿美元

全球疏水交互作用层析法市场规模在2024年估计为4.959亿美元，预计到2030年将达到7.163亿美元，在分析期（2024-2030年）内复合年增长率（CAGR）为6.3%。本报告分析的细分市场之一－树脂，预计将以7.3%的复合年增长率成长，并在分析期间结束时达到2.631亿美元。缓衝液细分市场预计在分析期间将以6.3%的复合年增长率成长。

美国市场规模估计为1.289亿美元，而中国市场预计将以9.6%的复合年增长率成长。

据估计，2024年美国疏水交互作用层析法市场规模将达到1.289亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到1.702亿美元，在2024年至2030年的分析期内，复合年增长率（CAGR）将达到9.6%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期间内，两国的复合年增长率分别为3.2%和5.8%。在欧洲，德国的复合年增长率预计约为3.7%。

全球疏水交互作用层析法市场—关键趋势与驱动因素概述

疏水交互作用层析法能否改变蛋白质纯化和生物製药领域的模式？

疏水交互作用层析法(HIC) 是蛋白质纯化中的一项重要技术，但为何它在生物製药开发、生物化学研究和工业蛋白质生产中如此重要？疏水交互作用层析法是一种强大的技术，可根据蛋白质、胜肽和其他生物分子的疏水性进行分离和纯化。在 HIC 中，生物分子被送至装有疏水性固定相的层析管柱。透过调节流动相中的盐浓度，研究人员可以控制蛋白质与疏水錶面的结合或洗脱方式，从而实现复杂混合物的精确分离。

疏水相互作用色谱 (HIC) 的重要性在于其能够在不使蛋白质变性的情况下纯化蛋白质，这对于维持其生物活性至关重要。这一特性使得 HIC 成为生物製药行业的首选技术，因为在生物製药行业中，蛋白质、抗体和其他生物分子必须经过纯化才能用于治疗应用。 HIC在疏水交互作用层析法为纯化复杂的生物分子提供了一种可靠且高效的方法，因此在生产药物开发、诊断和研究所需的高纯度蛋白质方面发挥核心作用。

技术进步如何改善疏水交互作用层析法在生物技术和製药应用的效果？

技术进步显着提升了疏水交互作用层析法（ HIC）的性能，使其成为现代生物製药和科研应用中更有效率、扩充性和适应性的技术。其中一项关键进展是开发出具有优化疏水配体的高性能树脂和固定相。这些树脂提高了结合特异性和容量，从而能够更有效地分离不同疏水性的蛋白质。现代HIC树脂具有更高的分辨率，能够纯化结构密切相关的生物分子，例如蛋白质异构体和抗体变体。这在生物治疗药物生产中至关重要，因为纯度是其首要考虑因素。

疏水相互作用层析 (HIC) 技术的另一项重要进展是能够根据特定生物分子来客製化固定相的疏水性。树脂化学的进步使得透过改变配体的类型和密度来调节疏水性成为可能，使研究人员能够精细地控制分离过程。这种灵活性在单株抗体纯化等应用中尤其重要，因为疏水性的细微差异会影响最终产品的功效。客製化的 HIC 树脂可确保蛋白质在温和条件下纯化，从而保持其天然构象和生物活性，这对于治疗性蛋白质至关重要。

自动化疏水相互作用色谱（HIC）系统已成为一项重要的技术进步，显着提高了层析法分离过程的效率和重现性。自动化系统能够精确控制流速、盐梯度和柱上样量，从而实现高度可控且可重复的分离过程。自动化减少了人为误差和变异性，使其在大规模生物製药生产中至关重要，因为稳定的产品纯度是关键。将HIC整合到自动化系统中，简化了生物製造的下游步骤，实现了更快、更扩充性的蛋白质纯化工作流程。

混合模式层析法的进步，将疏水交互作用与其他分离技术（例如离子交换色谱和亲和性）相结合，进一步拓展了疏水相互作用色谱（HIC）的应用范围。这些混合技术能够基于多种性质（例如电荷和疏水性）同时分离生物分子。混合模式HIC已被证明在纯化复杂生物製药（例如融合蛋白、抗体药物复合体（ADC）和其他多功能治疗药物）方面尤为有效。这些进步带来了更稳健、更灵活的纯化工艺，减少了纯化步骤，提高了整体生物製程效率。

为了加速疏水相互作用色谱（HIC）条件的最佳化，研究人员开发了高通量筛检方法。这些方法使研究人员能够并行快速评估多种树脂类型、缓衝液条件和盐梯度，从而确定纯化特定生物分子的最佳设定。高通量技术在药物发现的早期阶段尤其重要，因为此时时间和资源效率至关重要。透过加速优化过程，这些技术有助于更快地将生物製药产品推向市场，同时确保产品的高纯度和高品质。

另一项重要进展是可扩展的疏水相互作用色谱（HIC）平台的开发，这些平台可以轻鬆地从实验室规模的纯化扩展到大规模工业生产。这种可扩展性在生物製药生产中尤其重要，因为生物製药生产需要生产大量的纯化蛋白质和抗体，这就要求层析法系统能够在规模扩大时保持性能。可扩展的HIC树脂和系统能够实现从研究到商业化的无缝过渡，确保纯化过程的一致性和可靠性，而与生产规模无关。

为什么疏水交互作用层析法在蛋白质纯化和生物製药生产中如此重要？

疏水交互作用层析法（ HIC）在蛋白质纯化和生物製药生产中至关重要，因为它提供了一种基于疏水交互作用分离生物分子的独特方法，同时也能维持蛋白质的天然结构和功能。 HIC 特别重要的关键原因在于，它能够在不使蛋白质暴露于可能导致其变性或惰性的恶劣条件下进行纯化。许多蛋白质，尤其是用于生物製药的蛋白质，对温度、pH 值和离子强度的变化非常敏感。 HIC 在相对温和的条件下进行，并使用水性缓衝体系，从而在整个纯化过程中维持蛋白质的稳定性。这使其成为纯化必须保持生物活性的治疗性蛋白质的理想技术。

疏水相互作用层析 (HIC) 在单株抗体 (mAb) 的纯化中也至关重要。单株抗体广泛用于治疗多种疾病，包括癌症和自体免疫疾病。单株抗体通常需要高度特异性的纯化工艺，以确保其不含宿主细胞蛋白、DNA 和製程相关杂质等污染物。 HIC 尤其擅长将抗体与聚集体、片段和其他错误折迭的蛋白质分离，从而确保生产出高纯度的生物疗法药物。 HIC 提供的精确性是抗体下游加工的关键环节，有助于提高这些药物的安全性和有效性。

除了治疗性蛋白质和抗体外，疏水性相互作用色谱 (HIC) 也用于纯化疫苗成分、酵素和其他生物製药产品。 HIC 能够基于疏水性的细微差异分离蛋白质，因此在需要高纯度分离的场合（例如重组蛋白生产）尤为重要。许多重组蛋白在宿主细胞（例如细菌或酵母）中表达，必须与含有宿主细胞蛋白和其他杂质的复杂混合物分离。 HIC 提供了一种高效的蛋白质纯化方法，可在去除不需要的成分的同时，维持目标分子的活性。

HIC对生物製药生产至关重要的另一个原因是它与其他层析法技术的兼容性。生物製程通常采用多步骤串联层析法法以达到所需的纯度。在亲和性和层析法或离子交换层析法等初始纯化步骤之后，HIC被广泛用于进一步纯化产品。 HIC与其他技术的互补性使其成为建构稳健纯化策略的多功能工具，这些策略可根据特定生物分子进行客製化。透过将HIC与其他纯化方法结合，生产商可以获得更高的产量、更高的纯度和更有效率的生产流程。

在研发领域，疏水相互作用色谱（HIC）在蛋白质表征和结构分析中发挥重要作用。此技术可用于分析蛋白质的疏水性及其与疏水錶面的相互作用，从而深入了解蛋白质的折迭、稳定性和功能。这些见解对于药物发现和开发至关重要，因为了解治疗性蛋白质在不同条件下的行为有助于设计更有效的治疗方法。此外，HIC 能够基于疏水性分离蛋白质，使其成为研究蛋白质-蛋白质相互作用、聚集倾向以及转译后修饰效应的有效工具。

在工业应用中，疏水相互作用色谱 (HIC) 用于大规模纯化蛋白质、酵素和其他需要严格品管的生物製药。由于其扩充性和持续生产高纯度产品的能力，HIC 系统在商业生物製药生产中至关重要。随着对生物製药的需求不断增长，HIC 提供了一种高效可靠的方法，既能满足生产需求，也能确保最终产品的安全性和有效性。其在确保产品品质和一致性方面发挥关键作用，对于生物製药的监管合规性和市场核准至关重要。

哪些因素正在推动疏水交互作用层析法市场的成长？

推动疏水交互作用层析法（ HIC）市场快速增长的因素有很多，包括生物製药需求的不断增长、蛋白质药物研发的进步以及医疗领域对生物製药日益增长的关注。其中一个关键驱动因素是生物製药产业的扩张，这带动了对高纯度蛋白质、抗体和疫苗的需求。生物製药已成为药物研发的重点领域，尤其是在癌症、自体免疫疾病和感染疾病的治疗方面。这些生物製药的生产需要精确且有效率的纯化工艺，这也推动了对HIC系统的需求。

单株抗体在多种疾病治疗的应用日益广泛，也是推动HIC市场发展的关键因素。单株抗体是成长最快的治疗药物类别之一，其生产需要严格的纯化以确保安全性和有效性。 HIC在单株抗体的纯化过程中发挥关键作用，能够将其与杂质、聚集体和不必要的形式分离，使其成为单株抗体生产中不可或缺的工具。随着抗体疗法市场的持续扩张，对HIC的需求也预计将随之成长。

生物製药产品（包括抗体药物复合体(ADC)、融合蛋白和生物相似药）日益复杂，也推动了疏水交互作用层析法 ( HIC) 市场的成长。这些复杂的生物製药需要精密的纯化策略才能可靠地分离不同的分子形式并达到所需的纯度。 HIC 能够基于疏水性分离蛋白质和生物分子，是纯化这些先进治疗药物的理想技术。随着生物製药公司不断创新并开发新型生物製药，HIC 将在生物製剂的生产中发挥越来越重要的作用。

层析法树脂和系统的技术进步进一步推动了疏水相互作用色谱（HIC）市场的成长。更高效、高容量树脂的开发提高了蛋白质纯化的分辨率和速度，使HIC成为一种更有效率、扩充性的工业应用技术。此外，自动化系统的引入减少了人工干预，提高了实验的重现性，使HIC更容易被企业采用。这些技术创新使得HIC对大规模生技製药企业以及从事药物研发的中小型生技公司都更具吸引力。

生物相似药（与已获核准的生物药物高度相似的生物製药药物）的兴起也推动了对高效纯化方法（如疏水相互作用色谱法，HIC）的需求。生物相似药生产商在寻求成本效益高的生产过程的同时，也要确保产品品质和安全性，而HIC提供了一种可靠的解决方案，可确保高纯度蛋白质的生产。随着生物相似药在全球市场核准和应用，对HIC系统的需求预计将会成长。

最后，生物製药监管要求日益重视产品的纯度和质量，推动了对先进纯化技术的需求。美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 等监管机构要求生物製药生产商证明其产品符合严格的纯度标准。疏水相互作用色谱 (HIC) 被广泛认为是实现这些标准的可靠有效技术，并已成为生物製药生产过程中的关键组成部分。

随着生物疗法需求的增长、生物製药行业的蓬勃发展以及蛋白质纯化技术的进步，疏水交互作用层析法（ HIC）市场预计将持续扩张。生物製药公司致力于优化纯化流程并高效生产高纯度产品，HIC 仍将是下一代生物製药生产中不可或缺的工具。

部分：

产品及服务（树脂、层析管、缓衝溶液及其他产品及服务）、样本（单株抗体、疫苗及其他样本）

受访公司范例

  • Avantor Performance Materials LLC
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • JNC Corporation
  • Knauer GmbH
  • Merck KgaA
  • Mitsubishi Chemical Corporation
  • Sartorius AG
  • Sepax Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Waters Corporation

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来变革市场和竞争情报。

Market Glass, Inc. 并没有查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在国、製造地以及进出口（成品和OEM产品）情况，预测企业竞争格局的变化。这种复杂多变的市场现实将对竞争对手产生多方面的影响，包括销货成本增加、盈利下降和供应链重组，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP12505

Global Hydrophobic Interaction Chromatography Market to Reach US$716.3 Million by 2030

The global market for Hydrophobic Interaction Chromatography estimated at US$495.9 Million in the year 2024, is expected to reach US$716.3 Million by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Resins, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$263.1 Million by the end of the analysis period. Growth in the Buffers segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$128.9 Million While China is Forecast to Grow at 9.6% CAGR

The Hydrophobic Interaction Chromatography market in the U.S. is estimated at US$128.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$170.2 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Hydrophobic Interaction Chromatography Market - Key Trends and Drivers Summarized

Is Hydrophobic Interaction Chromatography the Game-Changer for Protein Purification and Biopharmaceuticals?

Hydrophobic interaction chromatography (HIC) is a vital technique in protein purification, but why is it so critical for biopharmaceutical development, biochemical research, and industrial protein production? Hydrophobic interaction chromatography is a powerful method used to separate and purify proteins, peptides, and other biomolecules based on their hydrophobicity. In HIC, biomolecules are applied to a chromatography column that contains a hydrophobic stationary phase. By manipulating the salt concentration in the mobile phase, researchers can control how proteins bind to or elute from the hydrophobic surface, allowing for precise separation of complex mixtures.

The significance of HIC lies in its ability to purify proteins without denaturing them, which is crucial for maintaining their biological activity. This makes HIC a preferred technique in the biopharmaceutical industry, where proteins, antibodies, and other biomolecules need to be purified for therapeutic use. HIC is particularly effective in downstream processing, where it is used to remove impurities and contaminants from recombinant proteins and monoclonal antibodies. By providing a reliable and efficient method for purifying complex biomolecules, hydrophobic interaction chromatography is central to the production of high-purity proteins essential for drug development, diagnostics, and research.

How Have Technological Advancements Improved Hydrophobic Interaction Chromatography for Biotech and Pharma?

Technological advancements have significantly enhanced hydrophobic interaction chromatography, making it more effective, scalable, and adaptable for modern biopharmaceutical and research applications. One of the key advancements has been the development of high-performance resins and stationary phases with optimized hydrophobic ligands. These resins improve binding specificity and capacity, allowing for more efficient separation of proteins with varying degrees of hydrophobicity. Modern HIC resins offer greater resolution, enabling the purification of closely related biomolecules, such as protein isoforms and antibody variants, which is critical in the production of biotherapeutics where purity is paramount.

Another important development in HIC technology is the ability to tailor the hydrophobicity of the stationary phase to suit specific biomolecules. Advances in resin chemistry have made it possible to adjust the degree of hydrophobicity by modifying ligand types and densities, allowing researchers to fine-tune the separation process. This flexibility is especially valuable in applications like monoclonal antibody purification, where slight variations in hydrophobicity can impact the final product’s efficacy. Tailored HIC resins ensure that proteins are purified under mild conditions, preserving their native conformation and biological activity, which is crucial for therapeutic proteins.

Automated HIC systems have also emerged as a major technological advancement, improving the efficiency and reproducibility of the chromatography process. Automated systems allow for precise control of flow rates, salt gradients, and column loading, ensuring that the separation process is highly controlled and reproducible. Automation reduces human error and variability, which is essential in large-scale biopharmaceutical production where consistency in product purity is critical. The integration of HIC into automated systems has streamlined downstream processing in biomanufacturing, allowing for faster and more scalable protein purification workflows.

Advancements in mixed-mode chromatography, which combines hydrophobic interaction with other separation techniques like ion exchange or affinity chromatography, have further expanded the applications of HIC. These hybrid approaches allow for the simultaneous separation of biomolecules based on multiple characteristics, such as charge and hydrophobicity. Mixed-mode HIC has proven especially useful in purifying complex biologics like fusion proteins, antibody-drug conjugates (ADCs), and other multimodal therapeutic agents. This advancement provides a more robust and flexible purification process, reducing the number of purification steps and enhancing overall efficiency in bioprocessing.

High-throughput screening methods have also been developed to accelerate the optimization of HIC conditions. These methods allow researchers to quickly evaluate multiple resin types, buffer conditions, and salt gradients in parallel, identifying the optimal settings for purifying a particular biomolecule. High-throughput techniques are particularly valuable in early-stage drug development, where time and resource efficiency are critical. By speeding up the process of condition optimization, these techniques help bring biopharmaceutical products to market faster while ensuring high levels of purity and quality.

Another significant advancement is the development of scalable HIC platforms that can be easily adapted from laboratory-scale purification to large-scale industrial production. This scalability is particularly important in biopharmaceutical manufacturing, where the need to produce large quantities of purified proteins or antibodies requires chromatography systems that maintain performance as they scale up. Scalable HIC resins and systems allow for a seamless transition from research to commercial production, ensuring that the purification process remains consistent and reliable, regardless of the production volume.

Why Is Hydrophobic Interaction Chromatography Critical for Protein Purification and Biopharmaceutical Production?

Hydrophobic interaction chromatography is critical for protein purification and biopharmaceutical production because it offers a unique method of separating biomolecules based on hydrophobic interactions while preserving the native structure and function of proteins. One of the main reasons HIC is so important is its ability to purify proteins without subjecting them to harsh conditions that could denature or deactivate them. Many proteins, especially those used in biopharmaceuticals, are sensitive to changes in temperature, pH, or ionic strength. HIC operates under relatively mild conditions, using aqueous buffer systems that maintain protein stability throughout the purification process. This makes it an ideal technique for purifying therapeutic proteins that need to retain their biological activity.

HIC is also crucial for the purification of monoclonal antibodies (mAbs), which are widely used in the treatment of various diseases, including cancer and autoimmune disorders. Monoclonal antibodies often require highly specific purification processes to ensure that they are free from contaminants such as host cell proteins, DNA, and process-related impurities. HIC is particularly effective in separating antibodies from aggregates, fragments, and other forms of misfolded proteins, ensuring the production of high-purity biotherapeutics. The precision offered by HIC makes it a vital part of the downstream processing of antibodies, contributing to the safety and efficacy of these drugs.

In addition to therapeutic proteins and antibodies, HIC is also used in the purification of vaccine components, enzymes, and other biopharmaceuticals. The ability of HIC to separate proteins based on subtle differences in hydrophobicity is particularly valuable in cases where high-purity separation is needed, such as in the production of recombinant proteins. Many recombinant proteins are expressed in host cells like bacteria or yeast, where they must be isolated from a complex mixture of host cell proteins and other impurities. HIC provides an efficient way to purify these proteins, removing unwanted components while maintaining the activity of the target molecule.

Another reason HIC is essential for biopharmaceutical production is its compatibility with other chromatographic techniques. In bioprocessing, multiple chromatography steps are often used in sequence to achieve the desired level of purity. HIC is commonly used after initial purification steps such as affinity chromatography or ion exchange chromatography to further refine the product. Its ability to complement other techniques makes HIC a versatile tool for building robust purification strategies that can be tailored to specific biomolecules. By integrating HIC with other purification methods, manufacturers can achieve higher yields, greater purity, and more efficient production processes.

In research and development, HIC plays a key role in protein characterization and structural studies. The technique can be used to analyze the hydrophobicity of proteins and their interaction with hydrophobic surfaces, providing valuable insights into protein folding, stability, and function. These insights are critical for drug discovery and development, where understanding the behavior of therapeutic proteins under different conditions can guide the design of more effective treatments. HIC’s ability to separate proteins based on hydrophobicity also makes it a valuable tool for studying protein-protein interactions, aggregation tendencies, and the effects of post-translational modifications.

In industrial applications, HIC is used for the large-scale purification of proteins, enzymes, and other biologics that require stringent quality control. The scalability of HIC systems, along with their ability to consistently produce high-purity products, makes them indispensable in the commercial production of biopharmaceuticals. As the demand for biologic drugs continues to grow, HIC provides an efficient and reliable method for meeting production needs while maintaining the safety and efficacy of the final product. Its role in ensuring product quality and consistency is critical for regulatory compliance and market approval of biopharmaceuticals.

What Factors Are Driving the Growth of the Hydrophobic Interaction Chromatography Market?

Several factors are driving the rapid growth of the hydrophobic interaction chromatography market, including the increasing demand for biopharmaceuticals, advancements in protein-based drug development, and the growing focus on biologics in medical treatments. One of the primary drivers is the expanding biopharmaceutical industry, where the need for high-purity proteins, antibodies, and vaccines is growing. Biologics have become a key area of focus in drug development, particularly in therapies for cancer, autoimmune diseases, and infectious diseases. As the production of these biologics requires precise and efficient purification processes, the demand for HIC systems is rising.

The growing adoption of monoclonal antibodies in the treatment of various medical conditions is another significant factor driving the HIC market. Monoclonal antibodies are among the fastest-growing classes of therapeutic drugs, and their production requires rigorous purification to ensure safety and efficacy. HIC plays a critical role in purifying monoclonal antibodies by separating them from impurities, aggregates, and unwanted forms, making it an indispensable tool in their manufacturing. As the market for antibody-based therapies continues to expand, the demand for HIC is expected to rise accordingly.

The increasing complexity of biopharmaceutical products, such as antibody-drug conjugates (ADCs), fusion proteins, and biosimilars, is also contributing to the growth of the hydrophobic interaction chromatography market. These complex biologics require sophisticated purification strategies to ensure the separation of different molecular forms and achieve the desired purity levels. HIC’s ability to resolve proteins and biomolecules based on their hydrophobicity makes it an ideal technique for purifying these advanced therapeutics. As biopharmaceutical companies continue to innovate and develop new classes of biologic drugs, HIC will play an increasingly important role in their production.

Technological advancements in chromatography resins and systems are further fueling the growth of the HIC market. The development of more efficient and high-capacity resins has improved the resolution and speed of protein purification, making HIC more effective and scalable for industrial use. In addition, the integration of automated systems has made HIC more accessible to companies by reducing manual intervention and improving reproducibility. These technological innovations are making HIC a more attractive option for both large-scale biopharmaceutical manufacturers and smaller biotech firms engaged in drug development.

The rise of biosimilars-biopharmaceutical products that are highly similar to already-approved biologics-is also driving demand for efficient purification methods like HIC. As biosimilar manufacturers seek to develop cost-effective production processes while maintaining the quality and safety of their products, HIC offers a reliable solution for ensuring high-purity protein production. With the growing approval and adoption of biosimilars in global markets, the demand for HIC systems is expected to increase.

Lastly, regulatory requirements for biopharmaceuticals are placing greater emphasis on product purity and quality, driving the need for advanced purification technologies. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require biopharmaceutical manufacturers to demonstrate that their products meet stringent purity standards. HIC is widely recognized as a robust and reliable technique for achieving these standards, making it a critical component of the biomanufacturing process.

With the rising demand for biologic therapies, the growth of the biopharmaceutical industry, and advancements in protein purification technologies, the hydrophobic interaction chromatography market is poised for continued expansion. As biopharmaceutical companies seek to optimize their purification workflows and produce high-purity products efficiently, HIC will remain an essential tool in the production of next-generation biologics.

SCOPE OF STUDY:

The report analyzes the Hydrophobic Interaction Chromatography market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Services (Resins, Columns, Buffers, Other Product & Services); Sample (Monoclonal Antibodies, Vaccines, Other Samples)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 11 Featured) -

  • Avantor Performance Materials LLC
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • JNC Corporation
  • Knauer GmbH
  • Merck KgaA
  • Mitsubishi Chemical Corporation
  • Sartorius AG
  • Sepax Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Waters Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Hydrophobic Interaction Chromatography - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Biopharmaceutical Purification and Separation Drives Growth in Hydrophobic Interaction Chromatography Market
    • Expansion of Protein and Antibody-based Therapeutics Spurs Adoption of Hydrophobic Interaction Chromatography
    • Growth in Focus on Improving Protein Separation and Purification Efficiency Expands Addressable Market for Hydrophobic Interaction Chromatography
    • Role of Hydrophobic Interaction Chromatography in Enhancing Downstream Bioprocessing Strengthens Business Case for Adoption
    • Increasing Focus on Chromatography Solutions for Monoclonal Antibodies and Vaccines Fuels Market Demand
    • Increasing Focus on Chromatography Solutions for Gene Therapy and Viral Vector Production Expands Addressable Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hydrophobic Interaction Chromatography Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Resins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Columns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Columns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Columns by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Buffers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Product & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Product & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Product & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • JAPAN
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • CHINA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • EUROPE
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • FRANCE
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • GERMANY
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • INDIA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • AFRICA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030

IV. COMPETITION